Cinacalcet 90 mg tablets recalled after failing dissolution specifications
Cinacalcet Tablets 90 mg from Strides Pharma are being recalled because they failed dissolution specifications. 6,672 bottles are affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for an out-of-specification dissolution result, with no health consequence stated in the source.
Plain-English summary
Cinacalcet Tablets, 90 mg, 30-count bottles, prescription only, manufactured by Strides Pharma Science Ltd. of Puducherry, India and distributed by Strides Pharma Inc. of East Brunswick, New Jersey, NDC 64380-885-04, are being recalled. The action covers 6,672 bottles.
The stated reason is failed dissolution specifications. The FDA classified the action as Class II. The source does not state a health consequence.
The affected lot is 7715893A, expiring 12/31/2027. Distribution was nationwide within the United States.
Patients holding the affected lot should speak to their pharmacist or prescriber before stopping treatment, and pharmacies should follow the instructions issued by the distributor.
The recalled product
- Product
- CINACALCET (CINACALCET)
- Brand
- CINACALCET
- Manufacturer
- Strides Pharma, Inc.
- Category
- Drug — Oral tablet
- Hazard
- dissolution-failure
- out-of-specification
- class-ii
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 7715893A
- Exp. Date 12/31/2027
UPCs (3)
- 0364380885047
- 0364380883043
- 0364380884040
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CINACALCET
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- HighCipla cinacalcet 60 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
- HighCipla cinacalcet 30 mg tablets exceed the nitrosamine daily intake limit
FDA (Drugs) · 2026-04-22
Same category
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighLEVOTHYROXINE SODIUM Tablets Recalled Due to Subpotent Drug Content
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls Rohto Dry-Aid Eye Drops Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- SevereDietary Supplement Modern Warrior Ready Recalled for Unapproved Ingredients
FDA (Food) · 2026-07-29
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-07-29